# FDA Inspection 1245306 - Novo Nordisk A/S - March 29, 2023

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/38a08e75-744a-489f-a0a5-baeee508c2ac
Source feed: FDA_Inspections

> FDA Inspection 1245306 for Novo Nordisk A/S on March 29, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1245306
- Company Name: Novo Nordisk A/S
- Inspection Date: 2023-03-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1165895 - 2019-12-05](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/1b2e0386-bb32-4a1e-b8c0-6bda25e404ad)
- [FDA Inspection 1057438 - 2018-05-18](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/a8be89b1-d4f3-429a-b42a-42db95754451)
- [FDA Inspection 1057438 - 2018-05-18](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/1523ef94-59fa-4e77-b51c-0451bb0318ed)
- [FDA Inspection 1007260 - 2017-02-08](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/f7c9c747-d7de-4a6c-9886-e185d08b2706)
- [FDA Inspection 964462 - 2016-04-08](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as/1797fe57-bbcd-43e9-a759-ae4f4dcdf134)

Company: https://www.keypedia.com/companies/novo-nordisk-as/99c36868-1f84-44c1-8e90-7abc30e92ec3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c